Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prevalent mutations in prostate cancer.

Jin-Tang Dong1

  • 1Department of Hematology and Oncology, Program in Genetics and Molecular Biology, Winship Cancer Institute, Emory University School of Medicine, 1365-C Clifton Road, Atlanta, GA 30322, USA. jin-tang.dong@emory.edu

Journal of Cellular Biochemistry
|November 4, 2005
PubMed
Summary

Genetic alterations drive prostate cancer development. Identifying and characterizing genes involved in familial and sporadic forms is crucial for improving detection and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zfhx3 is required for proper spindle assembly and chromosome segregation during oocyte meiosis I in mice.

Frontiers in cell and developmental biology·2026
Same author

Oncogenic role of the SLC7A13-SLC3A1 cystine transporter in human luminal breast cancer and its cryo-EM structure.

Protein & cell·2025
Same author

ZFHX3 is integral to androgen/AR signaling involving protein association with AR in prostate cancer cells.

Scientific reports·2025
Same author

An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer.

British journal of cancer·2024
Same author

Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts.

The Journal of clinical investigation·2024
Same author

Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus.

JCI insight·2024

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Prostate cancer arises from quantitative and structural genetic alterations.
  • Numerous genes are implicated through mutations and functional consequences.
  • Understanding these genetic factors is key to advancing prostate cancer research.

Purpose of the Study:

  • To review genes implicated in prostate cancer development and progression.
  • To categorize genes based on mutation type (germline, somatic) and association (familial, sporadic).
  • To highlight the need for further genetic and functional characterization of identified genes.

Main Methods:

  • Literature review of genetic alterations in prostate cancer.
  • Categorization of genes based on their role in familial and sporadic prostate cancer.

Related Experiment Videos

  • Analysis of gene mutations (germline, somatic) and copy number changes.

    • Main Results:

    • Identified genes with germline mutations in familial prostate cancer (e.g., ELAC2, MSR1, RNASEL).
    • Identified genes with somatic mutations in sporadic prostate cancer (e.g., AR, PTEN, p53).
    • Cataloged genes with germline variants and genomic copy number changes associated with prostate cancer risk.

    Conclusions:

    • Further identification and characterization of genes are essential for understanding prostate cancer.
    • Additional genetic, functional, and biochemical studies are needed for implicated genes.
    • Gene discovery and characterization represent a critical step towards improved prostate cancer detection and treatment.